Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Open-label Extension to Protocol 1042-0600

ClinicalTrials.gov ID: NCT00512317

Public ClinicalTrials.gov record NCT00512317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.

Study identification

NCT ID
NCT00512317
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Marinus Pharmaceuticals
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • ganaxolone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2007
Primary completion
Nov 30, 2009
Completion
Aug 31, 2013
Last update posted
Jan 16, 2023

2007 – 2013

United States locations

U.S. sites
25
U.S. states
21
U.S. cities
25
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294-0021
Barrow Neurological Institute Phoenix Arizona 85013
Arkansas Epilepsy Program Little Rock Arkansas 72205
University of Southern California Adult Comprehensive Epilepsy Center Los Angeles California 90033
University of California-Davis Sacramento California 95817
Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital Aurora Colorado 80010-0045
Yale University School of Medicine New Haven Connecticut 06520
University of Florida McKnight Brain Institute Gainesville Florida 32610-0236
Intercoastal Neurology Sarasota Florida 34232
Emory HealthCare Atlanta Georgia 30322
Southern Illinois University Medical Center Springfield Illinois 62702
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Kentucky, Dept. of Neurology Lexington Kentucky 40536
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817
2799 West Grand blvd. CFP 071 Detroit Michigan 48202
Minnesota Epilepsy Group, PA Saint Paul Minnesota 55102-2383
Comprehensive Epilepsy Care Center for Children and Adults Chesterfield Missouri 63017
Neurosciences Institute at Albany Medical Center Albany New York 12208
SUNY Upstate Medical University Syracuse New York 13210
Ohio State University Medical Center Columbus Ohio 43210
Riddle Health Care Center for Neuroscience Media Pennsylvania 19063
Thomas Jefferson University Philadelphia Pennsylvania 19107
Vanderbilt University Medical Center Nashville Tennessee 37232
Neurological Clinic of Texas, P.A. Dallas Texas 75230
Virginia Commonwealth University Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00512317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00512317 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →